![Fabrice Chouraqui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fabrice Chouraqui
Vorstandsvorsitzender bei
PHARMING GROUP N.V.
Vermögen: 216 913 $ am 31.05.2026
Profil
Fabrice Chouraqui is currently Chief Executive Officer & Executive Director at Pharming Group NV since 2025 and serves as an Independent Member on the Governors Board at Orano Med SAS. Former roles include Chief Executive Officer & Director at Cellarity Inc. and President at Novartis Pharmaceuticals Corp.
from 2016 to 2019.
Education includes an MBA from INSEAD and graduate and doctorate degrees from Universite Paris Cite.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMING GROUP NV 0,02 % | 31.03.2026 | 161.425 ( 0,02 % ) | 216 913 $ | 31.05.2026 |
Aktive Positionen von Fabrice Chouraqui
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMING GROUP N.V. | Vorstandsvorsitzender | 04.03.2025 |
Orano Med SAS
 Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Fabrice Chouraqui
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Präsident | 01.01.2019 |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Vorstandsvorsitzender | 12.05.2025 |
Ausbildung von Fabrice Chouraqui
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Wählen Sie MarketScreener 
